Thoralf Lange

7.1k total citations
113 papers, 4.0k citations indexed

About

Thoralf Lange is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Thoralf Lange has authored 113 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Hematology, 41 papers in Genetics and 23 papers in Oncology. Recurrent topics in Thoralf Lange's work include Chronic Myeloid Leukemia Treatments (47 papers), Hematopoietic Stem Cell Transplantation (41 papers) and Chronic Lymphocytic Leukemia Research (32 papers). Thoralf Lange is often cited by papers focused on Chronic Myeloid Leukemia Treatments (47 papers), Hematopoietic Stem Cell Transplantation (41 papers) and Chronic Lymphocytic Leukemia Research (32 papers). Thoralf Lange collaborates with scholars based in Germany, United States and Italy. Thoralf Lange's co-authors include Dietger Niederwieser, Michael W. Deininger, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Rainer Storb, Michael B. Maris, Haifa Kathrin Al‐Ali, Judith A. Shizuru and Barry E. Storer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Thoralf Lange

110 papers receiving 3.9k citations

Peers

Countries citing papers authored by Thoralf Lange

Since Specialization

Citations

This map shows the geographic impact of Thoralf Lange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thoralf Lange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thoralf Lange more than expected).

Fields of papers citing papers by Thoralf Lange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thoralf Lange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thoralf Lange. The network helps show where Thoralf Lange may publish in the future.

Co-authorship network of co-authors of Thoralf Lange

This figure shows the co-authorship network connecting the top 25 collaborators of Thoralf Lange. A scholar is included among the top collaborators of Thoralf Lange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thoralf Lange. Thoralf Lange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

#	Work	Indexed citations
1	Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia 2019 ·Journal of Molecular Diagnostics ·Georg‐Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, Michael Cross, Francis J. Giles, Martin C. Müller, Andreas Hochhaus, Dietger Niederwieser, Thoralf Lange	39
2	Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma 2018 ·Haematologica ·Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb	23
3	Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission 2017 ·Blood ·Juliane Grimm, Marius Bill, Madlen Jentzsch, (unknown), (unknown), (unknown), Julia Schulz, Michael Cross, Wolfram Pönisch, Vladan Vučinić, Gerhard Behre, Thoralf Lange, Georg‐Nikolaus Franke, Dietger Niederwieser, Sebastian Schwind	0
4	Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial 2017 ·Blood ·Georg‐Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, Christine Günther, Michael Cross, Thomas Ernst, (unknown), Dietger Niederwieser, Andreas Hochhaus, Thoralf Lange	1
5	Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial 2016 ·Annals of Oncology ·Julia Quidde, Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, (unknown), (unknown), Tanja Trarbach, Norbert Marschner, Hans‐Joachim Schmoll, Axel Hinke, Salah‐Eddin Al‐Batran, Dirk Arnold	18
6	Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial 2016 ·Annals of Oncology ·Julia Quidde, (unknown), Ullrich Graeven, C. Lerchenmueller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, (unknown), Andrea Tannapfel, Tanja Trarbach, Norbert Marschner, Hans‐Joachim Schmoll, Axel Hinke, S-E. Al-Batran, Dirk Arnold	0
7	Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL) 2015 ·Annals of Oncology ·Andreas Thiel, Johannes Schetelig, Wolfram Pönisch, K. Schäfer-Eckart, Walter E. Aulitzky, N. Peter, Antina Schulze, Georg Maschmeyer, (unknown), Regina Herbst, Annette Hänel, Anke Morgner, Frank Kroschinsky, Martin Bornhäuser, Thoralf Lange, Mathias Wilhelm, Dietger Niederwieser, G. Ehninger, F. Fiedler, Mathias Hänel	7
8	Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib 2015 ·Leukemia ·(unknown), (unknown), Stefan Wilop, (unknown), (unknown), Oliver Frank, Andreas Hochhaus, Francis J. Giles, Thoralf Lange, Marc Müller, Steffen Koschmieder, Fabian Beier, Patrick Ziegler, Tim H. Brümmendorf	18
9	Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial 2015 ·The Lancet Oncology ·Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Salah‐Eddin Al‐Batran, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, Andrea Tannapfel, Anke Reinacher‐Schick, Julia Quidde, Tanja Trarbach, Axel Hinke, Hans‐Joachim Schmoll, Dirk Arnold	176
10	A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation 2014 ·Haematologica ·Brian Kornblit, DG Maloney, Barry E. Storer, Michael B. Maris, Lars L. Vindeløv, Parameswaran Hari, Amelia Langston, Michael A. Pulsipher, Wolfgang Bethge, Thomas R. Chauncey, Thoralf Lange, Finn Bo Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, R Storb, Brenda M. Sandmaier	28
11	Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA 2013 ·Clinical Cancer Research ·Jacqueline Maier, Thoralf Lange, Irina Kerle, Katja Specht, Melanie Bruegel, Claudia Wickenhauser, Philipp J. Jost, Dietger Niederwieser, Christian Peschel, Justus Duyster, Nikolas von Bubnoff	60
12	Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia 2013 ·Leukemia & lymphoma ·(unknown), Simona Iacobelli, Sabine Leiblein, Ann‐Kathrin Eisfeld, Christian Pfrepper, Simone Heyn, Vladan Vučinić, Georg‐Nikolaus Franke, Rainer Krahl, Stephan Fricke, Cornelia Becker, Wolfram Pönisch, Gerhard Behre, Dietger Niederwieser, Thoralf Lange	3
13	Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective 2011 ·Onkologie ·Birgit Cremer, Brenda M. Sandmaier, Wolfgang Bethge, Thoralf Lange, Valentin Goede, Udo Holtick, Michael Hallek, Kai Hübel	5
14	A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib 2009 ·Haematologica ·Thomas Ernst, Franz Gruber, (unknown), Jacqueline Maier, Markus Pfirrmann, Marcus Müller, Ingvild Mikkola, Kimmo Porkka, D. Niederwieser, Andreas Hochhaus, Thoralf Lange	27
15	Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First Allografts 2009 ·Biology of Blood and Marrow Transplantation ·Boglarka Gyurkocza, Thai M. Cao, Rainer Storb, Thoralf Lange, Wendy M. Leisenring, Georg‐Nikolaus Franke, Mohamed L. Sorror, Richard T. Hoppe, David G. Maloney, Robert S. Negrin, Judith A. Shizuru, Brenda M. Sandmaier	22
16	Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting 2008 ·Blood ·Marcello Rotta, Barry E. Storer, Firoozeh Sahebi, Judith A. Shizuru, Benedetto Bruno, Thoralf Lange, Edward Agura, Peter A. McSweeney, Michael A. Pulsipher, Parameswaran Hari, Richard T. Maziarz, Thomas R. Chauncey, Frederick R. Appelbaum, Mohamed L. Sorror, William Bensinger, Brenda M. Sandmaier, Rainer Storb, David G. Maloney	71
17	A Novel Method to Quantify and Characterize Leukemia-Reactive Natural Killer Cells in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation following Conventional or Reduced-Dose Conditioning 2007 ·International Journal of Hematology ·Olaf Penack, Lars Fischer, Andrea Stroux, Chiara Gentilini, Axel Nogai, (unknown), Susanne Ganepola, Thoralf Lange, (unknown), (unknown), Igor W. Blau, Eckhard Thiel, (unknown)	2
18	Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease 2007 ·Gastrointestinal Endoscopy ·Susanne Neumann, Konrad Schoppmeyer, Thoralf Lange, Marcus Wiedmann, (unknown), Andrea Tannapfel, Joachim Mössner, Dietger Niederwieser, Karel Caca	47
19	Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors 2005 ·Journal of Clinical Oncology ·Ute Hegenbart, Dietger Niederwieser, Brenda M. Sandmaier, Michael B. Maris, Judith A. Shizuru, Hildegard Greinix, Catherine Cordonnier, Bernard Rio, Aloïs Gratwohl, Thoralf Lange, Haifa Kathrin Al‐Ali, Barry E. Storer, David G. Maloney, Peter A. McSweeney, Thomas R. Chauncey, (unknown), Benedetto Bruno, Richard T. Maziarz, Finn Bo Petersen, Rainer Storb	181
20	BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning 2004 ·Leukemia ·Thoralf Lange, Michael W. Deininger, R. Brand, Ute Hegenbart, Haifa Kathrin Al‐Ali, Rainer Krahl, (unknown), L. Uharek, Sabine Leiblein, Chiara Gentilini, Effie W. Petersdorf, Rainer Storb, Dietger Niederwieser	19

Work

Indexed citations

Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia

2019 ·Journal of Molecular Diagnostics ·Georg‐Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, Michael Cross, Francis J. Giles, Martin C. Müller, Andreas Hochhaus, Dietger Niederwieser, Thoralf Lange

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

2018 ·Haematologica ·Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

2017 ·Blood ·Juliane Grimm, Marius Bill, Madlen Jentzsch, (unknown), (unknown), (unknown), Julia Schulz, Michael Cross, Wolfram Pönisch, Vladan Vučinić, Gerhard Behre, Thoralf Lange, Georg‐Nikolaus Franke, Dietger Niederwieser, Sebastian Schwind

Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial

2017 ·Blood ·Georg‐Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, Christine Günther, Michael Cross, Thomas Ernst, (unknown), Dietger Niederwieser, Andreas Hochhaus, Thoralf Lange

Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial

2016 ·Annals of Oncology ·Julia Quidde, Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, (unknown), (unknown), Tanja Trarbach, Norbert Marschner, Hans‐Joachim Schmoll, Axel Hinke, Salah‐Eddin Al‐Batran, Dirk Arnold

Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial

2016 ·Annals of Oncology ·Julia Quidde, (unknown), Ullrich Graeven, C. Lerchenmueller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, (unknown), Andrea Tannapfel, Tanja Trarbach, Norbert Marschner, Hans‐Joachim Schmoll, Axel Hinke, S-E. Al-Batran, Dirk Arnold

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)

2015 ·Annals of Oncology ·Andreas Thiel, Johannes Schetelig, Wolfram Pönisch, K. Schäfer-Eckart, Walter E. Aulitzky, N. Peter, Antina Schulze, Georg Maschmeyer, (unknown), Regina Herbst, Annette Hänel, Anke Morgner, Frank Kroschinsky, Martin Bornhäuser, Thoralf Lange, Mathias Wilhelm, Dietger Niederwieser, G. Ehninger, F. Fiedler, Mathias Hänel

Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib

2015 ·Leukemia ·(unknown), (unknown), Stefan Wilop, (unknown), (unknown), Oliver Frank, Andreas Hochhaus, Francis J. Giles, Thoralf Lange, Marc Müller, Steffen Koschmieder, Fabian Beier, Patrick Ziegler, Tim H. Brümmendorf

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

2015 ·The Lancet Oncology ·Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller, B. Killing, Reinhard Depenbusch, Claus-Christoph Steffens, Salah‐Eddin Al‐Batran, Thoralf Lange, Georg Dietrich, Jan Stoehlmacher, Andrea Tannapfel, Anke Reinacher‐Schick, Julia Quidde, Tanja Trarbach, Axel Hinke, Hans‐Joachim Schmoll, Dirk Arnold

176

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

2014 ·Haematologica ·Brian Kornblit, DG Maloney, Barry E. Storer, Michael B. Maris, Lars L. Vindeløv, Parameswaran Hari, Amelia Langston, Michael A. Pulsipher, Wolfgang Bethge, Thomas R. Chauncey, Thoralf Lange, Finn Bo Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, R Storb, Brenda M. Sandmaier

Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

2013 ·Clinical Cancer Research ·Jacqueline Maier, Thoralf Lange, Irina Kerle, Katja Specht, Melanie Bruegel, Claudia Wickenhauser, Philipp J. Jost, Dietger Niederwieser, Christian Peschel, Justus Duyster, Nikolas von Bubnoff

Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

2013 ·Leukemia & lymphoma ·(unknown), Simona Iacobelli, Sabine Leiblein, Ann‐Kathrin Eisfeld, Christian Pfrepper, Simone Heyn, Vladan Vučinić, Georg‐Nikolaus Franke, Rainer Krahl, Stephan Fricke, Cornelia Becker, Wolfram Pönisch, Gerhard Behre, Dietger Niederwieser, Thoralf Lange

Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective

2011 ·Onkologie ·Birgit Cremer, Brenda M. Sandmaier, Wolfgang Bethge, Thoralf Lange, Valentin Goede, Udo Holtick, Michael Hallek, Kai Hübel

A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib

2009 ·Haematologica ·Thomas Ernst, Franz Gruber, (unknown), Jacqueline Maier, Markus Pfirrmann, Marcus Müller, Ingvild Mikkola, Kimmo Porkka, D. Niederwieser, Andreas Hochhaus, Thoralf Lange

Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First Allografts

2009 ·Biology of Blood and Marrow Transplantation ·Boglarka Gyurkocza, Thai M. Cao, Rainer Storb, Thoralf Lange, Wendy M. Leisenring, Georg‐Nikolaus Franke, Mohamed L. Sorror, Richard T. Hoppe, David G. Maloney, Robert S. Negrin, Judith A. Shizuru, Brenda M. Sandmaier

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting

2008 ·Blood ·Marcello Rotta, Barry E. Storer, Firoozeh Sahebi, Judith A. Shizuru, Benedetto Bruno, Thoralf Lange, Edward Agura, Peter A. McSweeney, Michael A. Pulsipher, Parameswaran Hari, Richard T. Maziarz, Thomas R. Chauncey, Frederick R. Appelbaum, Mohamed L. Sorror, William Bensinger, Brenda M. Sandmaier, Rainer Storb, David G. Maloney

A Novel Method to Quantify and Characterize Leukemia-Reactive Natural Killer Cells in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation following Conventional or Reduced-Dose Conditioning

2007 ·International Journal of Hematology ·Olaf Penack, Lars Fischer, Andrea Stroux, Chiara Gentilini, Axel Nogai, (unknown), Susanne Ganepola, Thoralf Lange, (unknown), (unknown), Igor W. Blau, Eckhard Thiel, (unknown)

Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease